Willem E. Fibbe

27.4k citations

215 papers · 19.4k indexed · 10 hit papers · h-index 59

Genetics top 0.01%
Surgery top 0.2%
Molecular Biology top 1%
Immunology top 0.5%
Hematology top 0.1%

Co-authors: Alma J. Nauta Maria Ester Bernardo Helene Roelofs Roel Willemze Franco Locatelli Sicco A. Scherjon Alwine B. Kruisselbrink Frans H.J. Claas
Topics: Mesenchymal stem cell research (82 papers)Hematopoietic Stem Cell Transplantation (80 papers)Immune Cell Function and Interaction (24 papers)
Cited by: Genetics Hematology Immunology
Journals: Proceedings of the National Academy of Sciences The Lancet JAMA
Partner nations: Netherlands Italy United States

In The Last Decade

Willem E. Fibbe

212 papers receiving 18.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

2008 2.0k citations Helene Roelofs, Maria Ester Bernardo et al. profile →
Immunomodulatory properties of mesenchymal stromal cells

2007 1.4k citations Alma J. Nauta, Willem E. Fibbe Blood profile →
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation

2013 1.1k citations Maria Ester Bernardo, Willem E. Fibbe profile →
Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta

2004 922 citations Frans H.J. Claas, Willem E. Fibbe et al. Stem Cells profile →
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

1997 771 citations Alfred H. Schinkel, Ulrich Mayer et al. Proceedings of the National Academy of Sciences profile →
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation

2003 590 citations Frans H.J. Claas, R. Willemze et al. Blood profile →
Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells

2006 569 citations Alma J. Nauta, Alwine B. Kruisselbrink et al. The Journal of Immunology profile →
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

2006 545 citations Alma J. Nauta, Geert Westerhuis et al. Blood profile →
Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cells

2008 542 citations Willem E. Fibbe, Hergen Spits et al. profile →
Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts

2013 339 citations Jaap Jan Zwaginga, Willem E. Fibbe et al. profile →

Peers

Countries citing papers authored by Willem E. Fibbe

Since Specialization

Citations

This map shows the geographic impact of Willem E. Fibbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willem E. Fibbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willem E. Fibbe more than expected).

Fields of papers citing papers by Willem E. Fibbe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willem E. Fibbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willem E. Fibbe. The network helps show where Willem E. Fibbe may publish in the future.

Co-authorship network of co-authors of Willem E. Fibbe

This figure shows the co-authorship network connecting the top 25 collaborators of Willem E. Fibbe. A scholar is included among the top collaborators of Willem E. Fibbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willem E. Fibbe. Willem E. Fibbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease 2022 ·Blood ·Astrid G. S. van Halteren,(unknown),(unknown),(unknown),Sandra Laban,Roula Tsonaka,(unknown),Anna‐Sophia Wiekmeijer,Melissa van Pel,Bart O. Roep,Jaap Jan Zwaginga,Arjan C. Lankester,Koen Schepers,Maarten J. D. van Tol,Willem E. Fibbe	2
2	Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study 2021 ·American Journal of Transplantation ·Marlies E. J. Reinders,(unknown),Sanne H. Hendriks,(unknown),(unknown),Aiko P. J. de Vries,Melissa van Pel,Helene Roelofs,Volkert A.L. Huurman,Pauline Meij,Dirk Jan A. R. Moes,Willem E. Fibbe,Frans H.J. Claas,Dave L. Roelen,Cees van Kooten,Jesper Kers,Sebastiaan Heidt,Ton J. Rabelink,Johan W. de Fijter	30
3	Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study 2020 ·American Journal of Transplantation ·(unknown),(unknown),Sebastiaan Heidt,Dave L. Roelen,Melissa van Pel,Helene Roelofs,Volkert A.L. Huurman,Ingeborg M. Bajema,Dirk Jan A. R. Moes,Willem E. Fibbe,Frans H.J. Claas,Cees van Kooten,Ton J. Rabelink,Johan W. de Fijter,Marlies E. J. Reinders	34
4	Visualizing Human Hematopoietic Stem Cell Trafficking In Vivo Using a Zebrafish Xenograft Model 2015 ·Stem Cells and Development ·Frank J. T. Staal,Herman P. Spaink,Willem E. Fibbe	24
5	Mesenchymal stromal cells and hematopoietic stem cell transplantation 2015 ·Immunology Letters ·Maria Ester Bernardo,Willem E. Fibbe	49
6	Intramyocardial Injection of Bone Marrow Mononuclear Cells in Patients with Chronic Myocardial Ischemia: an Intra-Patient Comparison 2011 ·Circulation ·(unknown),Jan van Ramshorst,Saskia L.M.A. Beeres,Petra Dibbets‐Schneider,(unknown),Willem E. Fibbe,Jaap Jan Zwaginga,Ernst E. van der Wall,M.J. Schalij,J. J. Bax,Douwe E. Atsma	2
7	Intramyocardial Bone Marrow Cell Injection in Patients with Chronic Myocardial Ischemia : Results Long Term Follow-Up 2011 ·Circulation ·(unknown),Jan van Ramshorst,Saskia L.M.A. Beeres,Petra Dibbets‐Schneider,(unknown),Willem E. Fibbe,Jaap Jan Zwaginga,E. E. van der Wall,M.J. Schalij,J. J. Bax,(unknown)	1
8	Abstract 15218: Intramyocardial Injection of Bone Marrow Mononuclear Cells in Patients with Chronic Myocardial Ischemia: an Intra-Patient Comparison 2011 ·Circulation ·(unknown),Jan van Ramshorst,Saskia L.M.A. Beeres,Petra Dibbets‐Schneider,A. Roos,Willem E. Fibbe,Jaap Jan Zwaginga,Ernst E. van der Wall,Martin J. Schalij,Jeroen J. Bax,Douwe E. Atsma	1
9	Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease 2011 ·Cytotherapy ·Marjolijn Duijvestein,Ilse Molendijk,Helene Roelofs,Anne Christine W. Vos,Auke P. Verhaar,Marlies E. J. Reinders,Willem E. Fibbe,Hein W. Verspaget,Gijs R. van den Brink,Manon E. Wildenberg,Daniël W. Hommes	40
10	Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingbreakdown → 2006 ·Blood ·Alma J. Nauta,Geert Westerhuis,Alwine B. Kruisselbrink,Ellie G.A. Lurvink,Roel Willemze,Willem E. Fibbe	545
11	Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cellsbreakdown → 2006 ·The Journal of Immunology ·Alma J. Nauta,Alwine B. Kruisselbrink,Ellie G.A. Lurvink,Roel Willemze,Willem E. Fibbe	569
12	Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation 2005 ·Bone Marrow Transplantation ·L.M. Ball,Arjan C. Lankester,Robbert G. M. Bredius,Willem E. Fibbe,Maarten J. D. van Tol,R. Maarten Egeler	30
13	Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization 2003 ·Blood ·Gerjo A. Velders,Ronald van Os,(unknown),(unknown),H. F. L. Guiot,I. J. D. Lindley,Roel Willemze,Ghislain Opdenakker,Willem E. Fibbe	43
14	Proteolytic Enzyme Levels Are Increased During Granulocyte Colony-Stimulating Factor-Induced Hematopoietic Stem Cell Mobilization in Human Donors but Do Not Predict the Number of Mobilized Stem Cells 2002 ·Journal of Hematotherapy & Stem Cell Research ·Ronald van Os,Marianke L.J. van Schie,R. Willemze,Willem E. Fibbe	20
15	Murine Hematopoietic Progenitor Cells With Colony-Forming or Radioprotective Capacity Lack Expression of the β2-Integrin LFA-1 1999 ·Blood ·Hans Pruijt,Yvette van Kooyk,Carl G. Figdor,Roel Willemze,Willem E. Fibbe	27
16	Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsbreakdown → 1997 ·Proceedings of the National Academy of Sciences ·Alfred H. Schinkel,Ulrich Mayer,Els Wagenaar,Carla A.A.M. Mol,Liesbeth van Deemter,(unknown),Martin A. van der Valk,Arie C. Voordouw,Hergen Spits,Olaf van Tellingen,J. M. J. M. Zijlmans,Willem E. Fibbe,Piet Borst	771
17	Differential short&hyphen;term and long&hyphen;term repopulating ability of stem cell subsets in mice 1997 ·Stem Cells ·Willem E. Fibbe,J. M. J. M. Zijlmans,Roel Willemze	7
18	Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase. 1996 ·The Journal of Experimental Medicine ·Henriëtte M. Goselink,Jo Van Damme,Pieter S. Hiemstra,A. Wuyts,Jan Stolk,Willem E. Fibbe,Roel Willemze,J.H. Frederik Falkenburg	15
19	Biology and treatment of myelodysplastic syndromes — developments in the past decade 1993 ·Annals of Hematology ·R. Willemze,Willem E. Fibbe,JH Falkenburg,Hanneke C. Kluin‐Nelemans,P. M. Kluin,J. E. Landegent	21
20	Epstein-Barr virus infection in allogeneic marrow grafting: lessons for transplant physicians and virologists 1992 ·Annals of Hematology ·Jan W. Gratama,M. A. P. Oosterveer,(unknown),Willem E. Fibbe,Olle Ringdén,Jaak M. Vossen,R. Willemze,R. L. H. Bolhuis,J. J. van Rood,Ingemar Ernberg	8

About Willem E. Fibbe

Willem E. Fibbe is a scholar working on Genetics, Hematology and Immunology, having authored 215 papers that have together received 19.4k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (82 papers), Hematopoietic Stem Cell Transplantation (80 papers) and Immune Cell Function and Interaction (24 papers). The work is most often cited by research in Genetics (11.1k citations), Hematology (3.9k citations) and Immunology (4.1k citations). Willem E. Fibbe has collaborated with scholars based in Netherlands, Italy and United States. Frequent co-authors include Alma J. Nauta, Maria Ester Bernardo, Helene Roelofs, Roel Willemze, Franco Locatelli, Sicco A. Scherjon, Alwine B. Kruisselbrink, Frans H.J. Claas, Ellie G.A. Lurvink and Humphrey H.H. Kanhai. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact